ErythropoieSIS stimulating agent (ESA) use is increased following missed dialysis sessions

ErythropoieSIS stimulating agent (ESA) use is increased following missed dialysis sessions

Missed dialysis sessions can have a cascading effect on patient clinical outcomes. In addition to missing the dialysis itself, patients fail to receive medications—such as ESAs—that are dosed at each session. This analysis assessed ESA dose changes following missed session episodes in order to evalu...

Full description

Bibliographic Details
Main Authors: T. Christopher Bond, Steven Wang, Jaime Rubin, Alex Yang
Format: Article
Language:English
Published: The Korean Society of Nephrology 2012-06-01
Series:Kidney Research and Clinical Practice
Online Access:http://www.sciencedirect.com/science/article/pii/S221191321200438X

Similar Items

Similar Items